Subscribe To
Gilead (gild) announces positive data on hepcludex for hdv
Gilead (GILD) Hepcludex meets the primary endpoint in a phase iiI study for the treatment of chronic he...
June 24, 2022, 2:00 pm
Biogen stops clinical trial tracking aduhelm
Biogen Inc. BiiB, +2.12% said in a statement that it stopped a post-marketing clinical trial testing it...
June 24, 2022, 8:12 am
Ortho regenerative technologies highlights milestones achieved in 1q ended april 30, 2022
Ortho Regenerative Technologies Inc (CSE:ORTH) has reported its financial results and highlights for the first quarter ended April 30, 2022. Among the...
June 24, 2022, 7:58 am
G-iii apparel group: why i'm optimistic on a rebound
G-iiI Apparel Group seems undervalued at the current price. It is uncertain whether recent COVID lockdo...
June 23, 2022, 5:53 pm
Here's why investors should retain hawaiian holdings (ha) now
Improvement in air-travel demand bodes well for Hawaiian Holdings (HA)....
June 23, 2022, 2:40 pm
Two-minute drill: lrcx, lii & vz
Burns McKinney, NFJ Investment Group, joins 'Closing Bell: Overtime to discuss volatility and the Fed, and what could spur the Fed to step back or be ...
June 22, 2022, 5:24 pm
Crispr therapeutics ag (crsp) management presents at innovation day conference (transcript)
CRISPR Therapeutics AG (NASDAQ:CRSP ) Innovation Day Conference Call June 21, 2022 2:00 PM ET Company Participants Samarth Kulkarni - Chief Executive ...
June 22, 2022, 11:40 am
Pfizer (pfe) to buy 8.1% stake in lyme disease vaccine partner
Pfizer (PFE) is set to acquire 8.1% stake in Valneva's stock. Valneva will use the cash from this investment to support its phase ...
June 21, 2022, 11:56 am
Insteel industries announces third quarter 2022 conference call
MOUNT AIRY, N.C.--(BUSINESS WIRE)--Insteel Industries Inc. (NYSE: iiIN) today announced that its third ...
June 21, 2022, 10:00 am
Astrazeneca hails phase iii success of drug for rare disease amyloid polyneuropathy
AstraZeneca PLC (LSE:AZN) will file a new drug application later this year after a successful phase iiI...
June 21, 2022, 3:34 am
Unicredit: no gift for russia
UniCredit won't completely write-off its Russian division. Russia Q1 performances were solid thanks to trading activities and N...
June 20, 2022, 10:09 am
Innovative industrial properties: short-term price loss, long-term potential
Despite a huge price loss in the past 7 months, iiPR has generated extraordinarily high returns for its...
June 19, 2022, 1:07 pm
Innovative industrial properties: far too cheap by any valuation metric
iiPR has been pummeled this year. However, its model has proven resilient and it should be fairly insul...
June 19, 2022, 2:36 am
14 june high-yield and high-rising dividend dogs ready to buy
June 2022, The AAii Journal listed two sets of stocks sorted as: High-Yielding Dividend Payers, and Big...
June 16, 2022, 11:09 pm
Syntax launches stratified total market ii etf
Syntax Advisors LLC has launched the Syntax Stratified Total Market ii ETF (NYSE Arca: SY...
June 16, 2022, 2:31 pm
Pfizer (pfe) covid pill ineffective in standard risk patients
Pfizer (PFE) stops enrolling patients in a phase ii/iiI ...
June 15, 2022, 4:58 pm
G-iii apparel (giii) buoyant on digital & brand strength
G-iiI Apparel's (GiiI) brand strength and robust busines...
June 15, 2022, 4:58 pm
Karyopharm therapeutics' shares slide after biogen terminates 2018 asset purchase agreement
Biogen Inc. (NASDAQ: BiiB) has informed Karyopharm Therapeutics Inc (NASDAQ: KPTI) that it has opted...
June 15, 2022, 4:58 pm
Two retailers the analysts are buying
The retail sector has had a hard time of it the last few months but now there are some opportunities emerging. Companies like Skechers (NYSE: SKX) and...
June 15, 2022, 10:03 am
Hyliion to participate in upcoming investor conferences
AUSTIN, Texas--(BUSINESS WIRE)--Hyliion Holdings Corp. (NYSE: HYLN) (“Hyl...
June 15, 2022, 9:22 am